Pseudoprogression in Previously Treated Patients with Non–Small Cell Lung Cancer Who Received Nivolumab Monotherapy-Reference-Cited by-同舟云学术

Pseudoprogression in Previously Treated Patients with Non–Small Cell Lung Cancer Who Received Nivolumab Monotherapy

Published:2019-03 Issue:3 Volume:14 Page:468-474
ISSN:1556-0864
Container-title:Journal of Thoracic Oncology
language:en
Short-container-title:Journal of Thoracic Oncology

Author:

Fujimoto Daichi,Yoshioka Hiroshige,Kataoka Yuki,Morimoto Takeshi,Hata Tae,Kim Young Hak,Tomii Keisuke,Ishida Tadashi,Hirabayashi Masataka,Hara Satoshi,Ishitoko Manabu,Fukuda Yasushi,Hwang Moon Hee,Sakai Naoki,Fukui Motonari,Nakaji Hitoshi,Morita Mitsunori,Mio Tadashi,Yasuda Takehiro,Sugita Takakazu,Hirai Toyohiro

Publisher

Elsevier BV

Subject

Pulmonary and Respiratory Medicine,Oncology

Reference14 articles.

1. Cancer statistics, 2017;Siegel;CA Cancer J Clin,2017

2. Non-small cell lung cancer: epidemiology, risk factors, treatment, and survivorship;Molina;Mayo Clin Proc,2008

3. Nivolumab versus docetaxel in advanced squamous-cell non-small-cell lung cancer;Brahmer;N Eng J Med,2015

4. Nivolumab versus docetaxel in advanced nonsquamous non-small-cell lung cancer;Borghaei;N Eng J Med,2015

5. Patients with melanoma treated with an anti-PD-1 antibody beyond RECIST progression: a US Food and Drug Administration pooled analysis;Beaver;Lancet Oncol,2018

Cited by 91 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A2ST-GCM: An adaptive spatio-temporal aware graph convolutional model for predicting pathological complete response in neoadjuvant therapy;Biomedical Signal Processing and Control;2025-01

2. Immunotherapy and Radiotherapy for Older Patients with Locally Advanced Non-Metastatic Non-Small-Cell Lung Cancer Who Are Not Candidates for or Decline Surgery and Chemotherapy: A Practical Proposal by the International Geriatric Radiotherapy Group;Cancers;2024-09-09

3. Longitudinal Changes of CT-radiomic and Systemic Inflammatory Features Predict Survival in Advanced Non–Small Cell Lung Cancer Patients Treated With Immune Checkpoint Inhibitors;Journal of Thoracic Imaging;2024-08-27

4. ESR Essentials: response assessment criteria in oncologic imaging—practice recommendations by the European Society of Oncologic Imaging;European Radiology;2024-08-13

5. Case report: Immune response characterization of a pseudoprogression in a PD-L1-negative, TMB-low, KEAP1/STK11 co-mutated metastatic NSCLC;Frontiers in Immunology;2024-08-07